Common disease-specific therapies included: interferon beta, glatiramer, baclofen, and stimulants in patients with MS; donepezil, and memantine in patients with AD; riluzole in patients with ALS; dopaminergic drugs in patients with PD; antithrombotics and cardiovascular medications in patients with stroke; and antiepileptics in patients with TBI (Table 5). This evidence concerns the gene IFNB1 and Stroke.